This course is part of PrimaryCareNOW: Live on June 9-11, 2026.
Obesity

Activity content starts in:

Industry Webcast

Obesity Care: Exploring Effects of a GLP-1 RA on a Complex DiseaseIndustry Webcast Sponsored by SPONSOR; Not for CME/CE Credit

Summarize efficacy and safety data for a glucagon-like peptide-1 receptor agonist (GLP-1 RA) when given alongside lifestyle intervention to adults with overweight or obesity. Review practical dosing, titration, and administration considerations.

 

CME/CE Information

0 Credits - Not for CME/CE Credit

Release Date: 6/10/2026

Expiration Date: 6/10/2026

Topics

Faculty

Holly F. Lofton, MD

Learn More

Supporters and Partners

Industry Sponsor

Novo Nordisk Inc.

Fine Print

The preferred browser is Google Chrome. If using a different browser, such as Safari, Firefox or Edge, make sure you are using the most up-to-date version. Your Internet settings should be set to accept cookies and JavaScript. If cookies and/or JavaScript are disabled, the site may not function properly. A high-speed Internet connection is not required; however, it is recommended for faster download times.

Obesity Care: Exploring Effects of a GLP-1 RA on a Complex Disease

Register